Delivery Order SPE2DE24D0013-SPE2D626F29EU
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $81.6K firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, for diagnostic reagents and test kits under the XPRS4PLEX-10 contract vehicle. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, is scheduled for completion by January 22, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for this procurement. Cepheid,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20.4K to Cepheid Inc. on January 13, 2026, for diagnostic testing supplies and reagents. This delivery order, designated XPRS4PLEX-10, is a child contract under a larger Indefinite Delivery Vehicle and carries a firm fixed-price structure with no set-aside designation. The order is scheduled for completion by January 21, 2026, and will be performed at Cepheid's headquarters location in Sunnyvale, California....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,200 to Cepheid Inc. on January 15, 2026, for diagnostic reagents and test kits under an existing Indefinite Delivery Contract framework. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 23, 2026, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's...
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc. on January 8, 2026, for molecular diagnostic reagents and test kits under a firm fixed-price structure. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 15, 2026, and represents a child order under a larger indefinite delivery contract vehicle. The work will be performed at Cepheid's headquarters in Sunnyvale, California. No set-aside designation was used for this...
- The Defense Logistics Agency Medical Supply Chain awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's broader indefinite delivery vehicle with the Department of Veterans Affairs VISN 6, valued at $32.8M and extending through September 30, 2030. The award carries no set-aside designation and is for the provision of...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. on January 21, 2026, for diagnostic reagents and test kits. This delivery order, valued at the ceiling amount, represents a child contract under Cepheid's larger Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, which is valued at $6.74 million through December 28, 2029. The delivery order is for...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,160 to Cepheid Inc. on January 20, 2026, for diagnostic reagents and test kits under a firm fixed-price arrangement. This delivery order, designated XPRS4PLEX-10, is a child contract to one of Cepheid's larger indefinite delivery contracts with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, which carries a total ceiling value of approximately $6.7 million through December...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F29EUDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $40.8K delivery order to Cepheid Inc. on January 27, 2026, for molecular diagnostic reagents and test kits under the XPRS4PLEX-10 contract vehicle. This delivery order, which is a child contract with a firm fixed-price structure and no set-aside designation, is scheduled for completion by February 3, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents continued procurement of diagnostic testing supplies from Cepheid, a leading federal supplier of advanced molecular diagnostic systems specializing in infectious disease detection through its GeneXpert diagnostic platform. This delivery order is issued under Cepheid's broader Indefinite Delivery Contract framework with the Department of Veterans Affairs and reflects the company's established position as a primary federal supplier of molecular diagnostics. Cepheid has demonstrated substantial capability through multiple existing contracts across the VA's Veterans Integrated Service Networks, the Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company's core offerings include diagnostic equipment, reagents, test kits, and maintenance services for conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases. The firm fixed-price structure and consistent award patterns indicate competitive positioning and proven delivery performance supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 1/26/26 |